Salubrum
PrivateLast Round
SAFE
Feb 9, 2026
Est. Valuation
$2M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Salubrum operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a SAFE round in February 2026.
Salubrum is a healthcare technology company that provides an AI-powered patient-intent scoring and marketing platform for healthcare organizations.
Sector
Healthcare & Life Sciences
Verticals
Patient Engagement, Healthcare Analytics, Marketing
Business Model
B2B
Customer Profile
Usage-Based SaaS, Subscription SaaS, Services & Consulting
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Salubrum Comparables
Compare Salubrum with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PurpleLab | 74% | |
| OptimizeRx Corporation | 73% | |
| Veeva Systems | 72% |
For institutional investors. Book with your work email.
Salubrum Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| SAFE | Feb 9, 2026 | ||||
| Pre Seed | Oct 20, 2025 | ||||
| Accelerator | Aug 1, 2024 | ||||
| Accelerator | Jun 24, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Salubrum Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Treefrog Accelerator | Accelerator |
| Draper Startup House | SAFE |
| uOttawa Entrepreneurship Hub | Accelerator |
| Forum Ventures | SAFE, Pre Seed |
| Coeus Collective Ventures | SAFE, Pre Seed |
| Next AI | SAFE, Pre Seed, Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 9, 2026
Raised a SAFE round with Coeus Collective Ventures and Draper Startup House.
- Oct 20, 2025
Partnered with Definitive Healthcare for patient activation services.
For institutional investors. Book with your work email.
Salubrum Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Salubrum's valuation, stock price, and market status.
Is Salubrum a public or private company?
Salubrum is a private company.
What is the current stock price of Salubrum?
Salubrum is a private company, so its shares have no public market price. Caplight tracks Salubrum's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Salubrum worth (valuation)?
Salubrum's valuation is estimated at $2.0M based on funding round data.
Can I buy Salubrum stock?
Salubrum shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Salubrum's last funding round?
Salubrum's most recent funding round was SAFE on February 9, 2026.
Who are the main investors in Salubrum?
Key investors in Salubrum include Forum Ventures.
Will Salubrum IPO soon?
No public IPO plans have been announced for Salubrum.
How can I track Salubrum secondary market activity?
Caplight tracks bids, offers, and trades in Salubrum's shares on secondary markets.